Mankind Pharma and Delhivery shares surge up to 4% after block deal

Shares of Mankind Pharma surged 4% to Rs 2,187.85, and Delhivery rose 2% to Rs 403.65 on the BSE following stake sales via block deals. Hema CIPEF (I), an affiliate of Capital Group, likely sold 0.9% of Mankind Pharma. Canada Pension Plan Investment reportedly offloaded 3.17% of Delhivery, valued at around Rs 886 crore. Official parties to the transactions are undisclosed.